Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07587762Not ApplicableCompleted

Predicting the Clinical Advantages of Speaking Valves Through Wearable Devices

Role: lead

NCT07424196Not Yet Recruiting

Physiological Benefits From the Removal of Tracheostomy Tubes (Obtained Via Wearable Devices)

Role: lead

NCT07198425Not Yet Recruiting

Predicting Success of Decannulation Using Wearable-derived Physiology

Role: lead

NCT07191080Enrolling By Invitation

Next-generation Sequencing Technology in the Clinical Application of Respiratory Specimens

Role: lead

All 4 trials loaded